***Requires Acetic Acid Water for reconstitution***

Discover the precision and reliability of the Supreme Peptides AOD-9604 Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “AOD-9604” and contains a premium synthetic peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on lipid metabolism, fat-reduction pathways, and metabolic signaling. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of human growth hormone (hGH 176–191) that has been widely studied for its potential to influence fat metabolism without directly stimulating broader growth hormone–related pathways. In research settings, it is primarily investigated for its role in lipolysis and inhibition of lipogenesis.

Product overview

AOD-9604 is a research-grade peptide engineered from the C-terminal fragment of growth hormone, designed for enhanced stability and targeted biological activity. Preclinical and clinical research associate AOD-9604 with increased fat breakdown, reduced fat accumulation, and modulation of metabolic pathways involved in adipose tissue regulation.

Key research features

Fat metabolism and lipolysis research:
AOD-9604 is widely studied for its potential to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage), making it relevant in experimental models of fat reduction.

Targeted metabolic activity:
Unlike full-length growth hormone, studies suggest AOD-9604 may exert effects on adipose tissue without significant impact on IGF-1 levels, supporting more targeted metabolic research.

Weight-management pathway investigation:
Research indicates AOD-9604 may influence body composition through modulation of fat metabolism pathways, making it valuable in studies focused on obesity and metabolic health.

AOD9604 – Suggested Use (Research Context)
Typical Dose: 200–500 mcg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional

Disclaimer:
This product is intended for research purposes only.
Not for human or animal consumption.
No medical claims are made.
Keep out of reach of children.